Skip to content

SDD-SOD-trial.

Selective Digestive Decontamination (SDD) and Selective Orophayngeal Decontamination (SOD) as Infection Prevention Measure in Intensive Care: Effects on Mortality and Antibiotic Resistance Development.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26718
Enrollment
3450
Registered
2005-09-06
Start date
2004-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients treated in Intensive Care Units.

Interventions

Selective Digestive Decontamination. Selective Oropharyngeal Decontamination.

Sponsors

participating centers, Dutch SDD Trialists Group
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to the ICU with an expected stay> 72 hours in ICU or with an expected duration of mechanical ventilation > 48 hours.

Exclusion criteria

Exclusion criteria: 1. Known allergy to study-medication in patient-history; 2. Pregnancy.

Design outcomes

Primary

MeasureTime frame
1. Hospital mortality; 2. ICU-mortality.

Secondary

MeasureTime frame
1. Prevalence of antibiotic resistance; 2. Duration of mechanical ventilation; 3. Duration of ICU-stay; 4. Incidence of hospital infections; 5. Antibiotic use; 6. Health care costs.

Contacts

Public ContactAnne Marie G.A. Smet, de

University Medical Center Utrecht (UMCU), AZU, P.O. Box 85500

a.desmet@azu.nl+31 (0)30 2509111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)